FIELD: medicine.
SUBSTANCE: group of inventions includes method of weakness, muscular involvement or sarcopeny treatment and application of 2-methylene-19-nor-20(S)-1α,25 -dihydroxyvitamin D3 used for production of medicinal agent for these pathological states. Invention provides effective treatment of weakness, muscular involvement or sarcopeny due to capacity of 2- methylene-19-nor-20(S)-1α,25- dihydroxyvitamin D3 to actively mobilise calcium of bones combined with now activity of bowels calcium transportation.
EFFECT: agent is characterised with high efficiency.
18 cl, 2 ex, 2 tbl, 2 dwg
Authors
Dates
2008-06-20—Published
2004-09-06—Filed